Paris, France

Yann Fargeaudou

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Assistance Publique-Hopitaux De Paris. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yann Fargeaudou. Retrieved from https://idiyas.com/inventor/yann-fargeaudou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Postpartum Care by Yann Fargeaudou

Introduction

Yann Fargeaudou is an innovative inventor based in Paris, France. He has made significant contributions to the field of medical prognosis, particularly concerning postpartum hemorrhage. His work aims to enhance patient management and outcomes through predictive testing.

Latest Patents

Yann Fargeaudou holds a patent for a method of prognosis associated with cases of postpartum hemorrhage. This novel approach provides a predictive test that enables healthcare practitioners to better manage patients suffering from this critical condition. The patent focuses on developing a scoring system based on various risk factors, which helps predict the necessity of invasive procedures to control bleeding.

Career Highlights

Fargeaudou is affiliated with Assistance Publique-Hôpitaux de Paris, where he applies his expertise in medical innovation. His work is pivotal in improving healthcare practices and patient safety in postpartum care.

Collaborations

Yann collaborates with notable colleagues, including Matthias Rossignol and Olivier Morel. Their combined efforts contribute to advancing medical technologies and improving patient care.

Conclusion

Yann Fargeaudou's innovative work in postpartum hemorrhage prognosis exemplifies the importance of predictive testing in healthcare. His contributions are vital for enhancing patient management and outcomes in critical situations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…